Back to Agenda
Conference Insights and Outcomes – Rapid Fire Session
Speaker(s)
Klaus Cichutek, PhD
Paul-Ehrlich-Institut, Germany
Director
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Isabelle de Zegher, DrMed, MD, MS, MSc
b!loba, Belgium
Founder
Danie Du Plessis, MD, MBA
The Next Version, United Kingdom
Managing Director and Owner
João Duarte, MPharm, MSc
Alexion, Astrazeneca Rare Disease, France
Senior Director,Business Planning and Operations, Regulatory and Quality Affairs
Robert Hemmings, MSc
Critical Path Institute, United States
Partner
Esteban Herrero-Martinez, PhD
AbbVie, United Kingdom
Director Regulatory Policy and Intelligence
Camille Metais, MSc
Alexion Pharma GmbH, Switzerland
Senior Director Regulatory Affairs
Claudine Sapède, PharmD
NOVARTIS INTERNATIONAL, Switzerland
Director, Global HTA Policy
Peter Schueler, DrMed, MD
ICON plc (CRO), Germany
Senior Vice President, Drug Development Neurosciences
Sabine Straus, MD, PhD, MSc
Medicines Evaluation Board (MEB), Netherlands
PRAC Chair, Staff Member
Koen Torfs
Actelion, Switzerland
Head of Market Access & Pricing
Rebecca A. Vermeulen, RPh
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Chris Walker, MSc
Amgen, United Kingdom
VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)
Have an account?